Enliven Therapeutics
Drug Discovery · Biotechnology
Listed: NASDAQ: ELVN2 legal entities
Facts
as of Nov 17, 2026We are a biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors to help patients with cancer live longer and better.
- Legal name
- Enliven Therapeutics, Inc.
- Headquarters
- Boulder, United States
- Founded
- 2016
- Employees
- 201-500estimated range
- Legal entities
- 2 in 1 countries
- Listing
- NASDAQ: ELVN
- Register numbers
- NAME enliven therapeutics inc
- Official records
- SEC CIK 1672619
- Website
- enliventherapeutics.com
These are the key facts about Enliven Therapeutics on Alion as of Nov 17, 2026. Enliven Therapeutics is headquartered in Boulder, United States. It was founded in 2016. It has raised $140.1M in 3 funding rounds. The latest round is Venture - Series Unknown of $90M, announced in 2024.
Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake
What the registers and the postings say about this employer.
Legal entity active
Enliven Therapeutics, Inc.
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices
Footprint
Hiring in 2 cities in 1 country.
2Cities
1Countries
Loading the map
| Site | Type | Open roles | Hires most for | Engineering |
|---|---|---|---|---|
| Boulder United States | Headquarters | 0 | ||
| Burlingame United States | Regional office | 0 |
Source: office addresses in postings and company registers
Financials
Funding rounds, investors and revenue on record.
$140.1MTotal raised
Venture - Series UnknownLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
Largest rounds and grants
Sources: funding announcements, grant and company registers
Milestones
Mar 21, 2024
Raised a round Venture round $90M · SEC Form D
Mar 15, 2019
Raised a round Venture round $44.1M · SEC Form D
2016
Founded
Each milestone is dated by its source: registers, filings, the press
